Folgen
Ryosuke TATEISHI
Ryosuke TATEISHI
Department of Gastroenterology, The University of Tokyo Graduate School of Medicine
Bestätigte E-Mail-Adresse bei umin.ac.jp - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee, J Jia, R Tateishi, ...
Hepatology international 11, 317-370, 2017
18962017
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
M Omata, LA Lesmana, R Tateishi, PJ Chen, SM Lin, H Yoshida, M Kudo, ...
Hepatology international 4, 439-474, 2010
12322010
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
S Shiina, T Teratani, S Obi, S Sato, R Tateishi, T Fujishima, T Ishikawa, ...
Gastroenterology 129 (1), 122-130, 2005
10322005
Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases
R Tateishi, S Shiina, T Teratani, S Obi, S Sato, Y Koike, T Fujishima, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2005
10272005
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors
S Shiina, R Tateishi, T Arano, K Uchino, K Enooku, H Nakagawa, ...
Official journal of the American College of Gastroenterology| ACG 107 (4 …, 2012
7962012
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
N Fujiwara, H Nakagawa, Y Kudo, R Tateishi, M Taguri, T Watadani, ...
Journal of hepatology 63 (1), 131-140, 2015
6362015
Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography
R Masuzaki, R Tateishi, H Yoshida, E Goto, T Sato, T Ohki, J Imamura, ...
Hepatology 49 (6), 1954-1961, 2009
5062009
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling
G He, D Dhar, H Nakagawa, J Font-Burgada, H Ogata, Y Jiang, ...
Cell 155 (2), 384-396, 2013
4832013
Evidence‐based C linical P ractice G uidelines for H epatocellular C arcinoma: The J apan S ociety of H epatology 2013 update (3rd JSH‐HCC G uidelines)
N Kokudo, K Hasegawa, M Akahane, H Igaki, N Izumi, T Ichida, S Uemoto, ...
Hepatology Research 45 (2), 2015
4712015
Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
N Kokudo, N Takemura, K Hasegawa, T Takayama, S Kubo, M Shimada, ...
Hepatology Research 49 (10), 1109-1113, 2019
4672019
Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors
K Uchino, R Tateishi, S Shiina, M Kanda, R Masuzaki, Y Kondo, T Goto, ...
Cancer 117 (19), 4475-4483, 2011
4412011
Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma
V Kumar, N Kato, Y Urabe, A Takahashi, R Muroyama, N Hosono, ...
Nature genetics 43 (5), 455-458, 2011
4362011
Radiofrequency ablation for hepatocellular carcinoma in so‐called high‐risk locations
T Teratani, H Yoshida, S Shiina, S Obi, S Sato, R Tateishi, N Mine, ...
Hepatology 43 (5), 1101-1108, 2006
3912006
Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update
M Kudo, Y Kawamura, K Hasegawa, R Tateishi, K Kariyama, S Shiina, ...
Liver cancer 10 (3), 181-223, 2021
3792021
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
R Tateishi, H Yoshida, S Shiina, H Imamura, K Hasegawa, T Teratani, ...
Gut 54 (3), 419-425, 2005
3142005
Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion
S Obi, H Yoshida, R Toune, T Unuma, M Kanda, S Sato, R Tateishi, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
2962006
Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation
M Omata, R Tateishi, H Yoshida, S Shiina
Gastroenterology 127 (5), S159-S166, 2004
2722004
APASL consensus statements and management algorithms for hepatitis C virus infection
M Omata, T Kanda, ML Yu, O Yokosuka, SG Lim, W Jafri, R Tateishi, ...
Hepatology International 6, 409-435, 2012
2382012
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review
R Tateishi, H Yoshida, Y Matsuyama, N Mine, Y Kondo, M Omata
Hepatology international 2, 17-30, 2008
2282008
Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management
M Akahane, H Koga, N Kato, H Yamada, K Uozumi, R Tateishi, T Teratani, ...
Radiographics 25 (suppl_1), S57-S68, 2005
2192005
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20